Skip to main content
Drug bottle and Pill

Compare Zepbound vs. Metformin

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Tirzepatide (Zepbound) and metformin (Glumetza) are both medications used to help manage conditions related to weight and insulin resistance. While tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist used for weight loss and sleep apnea, metformin is a biguanide primarily used for Type 2 diabetes. Tirzepatide is administered as a weekly subcutaneous injection, whereas metformin is taken orally, usually once or twice a day. Tirzepatide is available only as a brand-name medication, while metformin is available in both brand-name and generic forms. Common side effects of tirzepatide include nausea, diarrhea, and stomach pain; metformin can also cause diarrhea and nausea. Tirzepatide can interact with diabetes medications, warfarin (Jantoven, Coumadin), and birth control pills; metformin can also interact with other diabetes medications, as well as alcohol. Additionally, tirzepatide has a risk of thyroid cancer and pancreatitis, while metformin carries a risk of lactic acidosis and low vitamin B12 levels.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.